# OnCo record glp1-agonists-cancer-risk (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/glp1-agonists-cancer-risk/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "glp1-agonists-cancer-risk" ;
  schema:name "GLP-1 receptor agonists and obesity-related cancer risk"@en ;
  schema:description "GLP-1 agonists, the new weight-loss injections, lower weight by 15-20%. Early observational data suggest fewer obesity-related cancers in people who take them, but no trial has yet tested cancer as an outcome."@en ;
  schema:url <https://onco.cc/technologies/glp1-agonists-cancer-risk/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/GLP-1_receptor_agonist> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5572286> ;
  schema:citation <https://doi.org/10.1056/NEJMsr1606602>, <https://doi.org/10.1056/NEJMoa2307563> ;
  onco:status "emerging" ;
  onco:related <https://onco.cc/ideas/idea-prev-glp1-cancer-prevention-rct/>, <https://onco.cc/ideas/idea-prev-glp1-endometrial-hyperplasia/>, <https://onco.cc/ideas/idea-nl-glp1-adjuvant-hr-breast/> ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/nutrition-lifestyle/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/bariatric-surgery-cancer-incidence/>, <https://onco.cc/technologies/chemoprevention/>, <https://onco.cc/technologies/dietitian-led-weight-loss-breast/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:terms <https://onco.cc/terms/obesity-related-cancers/>, <https://onco.cc/terms/metabolic-syndrome/>, <https://onco.cc/terms/energy-balance/>, <https://onco.cc/terms/body-composition/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-funding-allocation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-lincoff-n-engl-j-med/> .